|
DNAJB9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66322511319095E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85640391947572E-12 |
| Normal-vs-Stage2 |
1.031480E-04 |
| Normal-vs-Stage3 |
7.044300E-04 |
| Normal-vs-Stage4 |
5.777400E-04 |
| Stage1-vs-Stage2 |
3.298400E-01 |
| Stage1-vs-Stage3 |
5.051000E-01 |
| Stage1-vs-Stage4 |
1.738960E-01 |
| Stage2-vs-Stage3 |
2.204000E-01 |
| Stage2-vs-Stage4 |
9.726300E-02 |
| Stage3-vs-Stage4 |
6.882000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63147273468667E-12 |
| Normal-vs-AfricanAmerican |
1.217450E-01 |
| Normal-vs-Asian |
5.683400E-01 |
| Caucasian-vs-AfricanAmerican |
1.78812999999112E-05 |
| Caucasian-vs-Asian |
2.840600E-01 |
| AfricanAmerican-vs-Asian |
9.888400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.42919998058488E-09 |
| Normal-vs-Female |
6.49780229622365E-12 |
| Male-vs-Female |
5.671700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.617800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.37760003404708E-09 |
| Normal-vs-Age(61-80Yrs) |
1.68310032577779E-10 |
| Normal-vs-Age(81-100Yrs) |
5.957500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.401000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.800090E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.060300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.686800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.843800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.651800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.868100E-02 |
| Normal-vs-Grade 2 |
8.02869992710953E-11 |
| Normal-vs-Grade 3 |
1.98249971994358E-10 |
| Normal-vs-Grade 4 |
6.500300E-02 |
| Grade 1-vs-Grade 2 |
3.397800E-01 |
| Grade 1-vs-Grade 3 |
6.794000E-01 |
| Grade 1-vs-Grade 4 |
2.445600E-01 |
| Grade 2-vs-Grade 3 |
4.335600E-01 |
| Grade 2-vs-Grade 4 |
2.150800E-04 |
| Grade 3-vs-Grade 4 |
1.180720E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
4.044900E-03 |
| ccA subtype-vs-ccB subtype |
4.96990000042885E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.28050023309834E-10 |
| Normal-vs-N1 |
2.497000E-01 |
| N0-vs-N1 |
8.753500E-02 |
|
|
